1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow LGL Leukemia: new trials by email Literature Review of LGL Leukemia trials Research Report on LGL Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL BNZ132-1-40 - LGL Leukemia, CTCL | Phase 1 / Phase 2 | Completed | Bioniz Therapeutics | 50 | 2018-04-01 | 2021-05-25 |
| Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia Cyclosporine, Gene expression analysis, Microarray analysis - Large Granular Lymphocytic Leukemia, LGL Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2006-06-01 | 2015-07-21 |
Leukemia, Large Granular Lymphocytic (2) · Leukemia (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2) · Leukemia, T-Cell (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Leukemia (1)
Cyclosporine (1) · Gene Expression Profiling (1) · Microarray Analysis (1)
Bioniz Therapeutics (1) · National Cancer Institute (NCI) (1)
United States (2)
Jonathan Brammer, MD, PhD (1) · Thomas Waldmann, M.D. (1)